DISCLOSURES: Supported in part by National Cancer Institute grant R25CA112486 and grant RC4CA153828 from the National Cancer Institute and the Office of the Director, National Institutes of Health to Jeffrey Weitzel and City of Hope, and also by support to Kenneth Offit from the Robert and Kate Niehaus Clinical Cancer Genetics Initiative, the Sharon Levine Corzine Fund at Memorial Sloan-Kettering Cancer Center, the Lymphoma Foundation, and the Esther and Hyman Rapport Philanthropic Trust.
State of the Art and Future Directions in the Era of Personalized Medicine
Article first published online: 19 AUG 2011
Copyright © 2011 American Cancer Society, Inc.
CA: A Cancer Journal for Clinicians
Volume 61, Issue 5, pages 327–359, September/October 2011
How to Cite
Weitzel, J. N., Blazer, K. R., MacDonald, D. J., Culver, J. O. and Offit, K. (2011), Genetics, genomics, and cancer risk assessment. CA: A Cancer Journal for Clinicians, 61: 327–359. doi: 10.3322/caac.20128
We are grateful to Peter Thom, MS, for his help with designing Figure §; to Dr. Stephen Gruber for his critical reading of the article; and to Tracy Sulkin and Shawntel Payton for assistance with preparation of the article. We also thank participants in the City of Hope Community Cancer Genetics and Research Training Intensive Course (National Cancer Institute grant R25CA112486; PI: J.N.W.) for providing insights about the challenges and rewards of providing genetic cancer risk assessment in community-based practices and the Cancer Genetics Community of Practice.
- Issue published online: 26 AUG 2011
- Article first published online: 19 AUG 2011
This article has been cited by:
- 1Communicating risk of hereditary breast and ovarian cancer with an interactive decision support tool, Patient Education and Counseling, 2013,, , , , , , , ,